ACH
Showing 1 - 25 of 578
Healthy Volunteers Trial in Melbourne (ACH-000029, Placebo)
Terminated
- Healthy Volunteers
- ACH-000029
- Placebo
-
Melbourne, Victoria, AustraliaNucleus Network Pty Ltd
Jan 30, 2023
Coronary Microvascular Disease, Coronary Vasospasm Trial in Mainz (Coronary physiology assessment)
Recruiting
- Coronary Microvascular Disease
- Coronary Vasospasm
- Coronary physiology assessment
-
Mainz, Rheinland-Pfalz, GermanyCenter of Cardiology, Cardiology I, university hospital Mainz
Nov 4, 2023
C3 Glomerulopathy, C3 Glomerulonephritis, Dense Deposit Disease Trial in United Kingdom, United States (Danicopan, Placebo)
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Worldwide (Danicopan)
Completed
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Florence, Italy
- +4 more
May 31, 2022
Healthy Adult Participants Trial in Baltimore (Treatment A, Treatment B, Treatment C)
Completed
- Healthy Adult Participants
- Treatment A
- +2 more
-
Baltimore, MarylandBaltimore Parexel EPCU
Jan 19, 2023
C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Worldwide (Danicopan)
Terminated
- C3 Glomerulonephritis
- +4 more
-
Birmingham, Alabama
- +12 more
Aug 9, 2022
Healthy Trial in Lincoln (ACH-0145228: Immediate Release, ACH-0145228: Powder-in-capsule)
Completed
- Healthy
- ACH-0145228: Immediate Release
- ACH-0145228: Powder-in-capsule
-
Lincoln, NebraskaClinical Trial Site
Dec 8, 2021
Healthy Trial in Ruddington (Danicopan Modified Release Prototype 1, Danicopan Modified Release Prototype 2, Danicopan Modified
Completed
- Healthy
- Danicopan Modified Release Prototype 1
- +2 more
-
Ruddington, Nottingham, United KingdomClinical Trial Site
Aug 16, 2021
Healthy Trial in Tempe (Danicopan: Powder-In-Capsule 1, Danicopan: Powder-In-Capsule 2, Danicopan: Tablet)
Completed
- Healthy
- Danicopan: Powder-In-Capsule 1
- +2 more
-
Tempe, ArizonaClinical Trial Site
Apr 8, 2022
C3 Glomerulonephritis, Dense Deposit Disease, C3 Glomerulopathy Trial in Melbourne, Antwerpen, Leiden (Danicopan)
Completed
- C3 Glomerulonephritis
- +4 more
-
Melbourne, Australia
- +2 more
Oct 7, 2021
C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Ranica (Non
Completed
- C3 Glomerulonephritis
- +4 more
- Non contrast-enhanced magnetic resonance imaging
-
Ranica, BG, ItalyCentro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Dac
Nov 24, 2021
Healthy Trial in Auckland (Danicopan - Tablet, Danicopan - Softgel, Danicopan - LFC)
Completed
- Healthy
- Danicopan - Tablet
- +2 more
-
Auckland, New ZealandClinical Trial Site
Jun 21, 2021
Achondroplasia, Hypochondroplasia Trial in Milan (Registry)
Recruiting
- Achondroplasia
- Hypochondroplasia
- Registry
-
Milan, ItalyMedical Genetics Unit, Fondazione IRCCS Ca' Granda Ospedale Magg
Apr 21, 2022
Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial in Italy, United Kingdom, United States (Danicopan, Eculizumab)
Active, not recruiting
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
-
Baltimore, Maryland
- +4 more
Aug 15, 2022